Skip to main content
NewslettersWatchlist

Cresco Labs Inc(CL-CN)
CSE

Today's Change
Delayed Last Update
Day Low1.5800
Day High1.7100
Open:1.5900
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Business Wire
Cresco Labs to Report Third Quarter 2024 Financial Results on November 8, 2024
Business Wire
Cresco Labs Opens Second Sunnyside in Miami, Florida
Business Wire
Cresco Labs Announces Fourth Quarter & Full Year 2022 Results
Business Wire
Cresco Labs Continues Florida Expansion with Two New Store Openings
Business Wire
Cresco Labs Celebrates New Sunnyside Dispensary Opening in South Orlando, Florida
Business Wire
Cresco Labs Reaches 60 Nationwide Dispensaries with the Opening of Two Florida Stores
Business Wire
Cresco Labs and Columbia Care Mutually Extend Acquisition Closing Timeline
Business Wire
Columbia Care and Cresco Labs Mutually Extend Acquisition Closing Timeline
Business Wire
Cresco Labs Opens New Sunnyside Dispensary in Daytona Beach, Florida
Business Wire
Cresco Labs Expands Sunnyside in Pennsylvania with 11th New Store
Business Wire
Cresco Labs Welcomes Patients to 22nd Sunnyside Dispensary in Florida
Business Wire
Cresco Labs Expands Retail Presence in Orlando, Florida
Business Wire
Cresco Labs Announces Conference Participation for December 2022
Business Wire
Cresco Labs Announces Third Quarter 2022 Results
Business Wire
Cresco Labs & Columbia Care Announce Planned Divestiture in Three Markets to Sean “Diddy” Combs, Creating the First Minority-Owned, Vertically Integrated Multi-State Cannabis Operator
Business Wire
Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022
Business Wire
Cresco Labs Announces Board Director Sidney Dillard’s Resignation
Business Wire
Cresco Labs Opens Second Pensacola Florida Dispensary
Business Wire
Cresco Labs’ Bestselling Flagship Brand Cresco Launches in Florida
Business Wire
Cresco Labs Closes Sale-and-Leaseback with Aventine Property Group for Brookville, PA Facility
Business Wire
Cresco Labs Announces Three New Sunnyside Dispensaries in Florida
Business Wire
Cresco Labs Announces Second Quarter 2022 Results

Profile

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and others. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.